Grand Pharmaceutical Group Limited (HK:0512) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Grand Pharmaceutical Group Limited anticipates a rise in consolidated net profit by over 50% for the first half of 2024 compared to the previous year, driven largely by a favorable change in fair value of an investment and the absence of one-off expenses from the prior period. The company’s unaudited financials are still pending finalization and are expected to be announced on August 19, 2024. Shareholders and potential investors are advised to exercise caution when trading company shares.
For further insights into HK:0512 stock, check out TipRanks’ Stock Analysis page.